TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36384100

Group type: EXPERIMENTAL
Intervention: Anakinra
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Recombinant interferon‐gamma
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study: 32151482

Group type: EXPERIMENTAL
Intervention: ProTaper Next (PTN)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: OneShape (OS)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: EdgeFile (EF X3)
Number of subjects: 27
Study: 33310432

Group type: EXPERIMENTAL
Intervention: 5 U-Turn Test (5UTT) - smartphone-based assessment of U-turn speed, self-administered daily for 14 days
Number of subjects: 76

Group type: COMPARATOR
Intervention: 5 U-Turn Test (5UTT) - smartphone-based assessment of U-turn speed
Number of subjects: 76
Study: 35487730

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg daily
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study: 34956430

Group type: COMPARATOR
Intervention: Adductor Canal Block (ACB) only
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combined Adductor Canal Block (ACB) and Popliteal Plexus Block (PPB)
Number of subjects: 60
Study: 35999026

Group type: EXPERIMENTAL
Intervention: Marstacimab (300 mg, 150 mg, or 450 mg weekly doses based on inhibitor status)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Marstacimab
Number of subjects: 26
Study: 33148701

Group type: EXPERIMENTAL
Intervention: Upadacitinib 15 mg once daily
Number of subjects: 1629

Group type: EXPERIMENTAL
Intervention: Adalimumab 40 mg every other week
Number of subjects: 1629

Group type: COMPARATOR
Intervention: Switch to adalimumab
Number of subjects: 1629

Group type: COMPARATOR
Intervention: Switch to upadacitinib
Number of subjects: 1629

Group type: EXPERIMENTAL
Intervention: Rescued patients
Number of subjects: 1629

Group type: COMPARATOR
Intervention: Both switch groups
Number of subjects: 1629
Study: 32067100

Group type: EXPERIMENTAL
Intervention: Less invasive surfactant administration (LISA)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Standard treatment (control group)
Number of subjects: 179
Study: 34182150

Group type: EXPERIMENTAL
Intervention: Budesonide Oral Suspension (BOS) 2.0 mg twice daily
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (BOS-PBO)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Budesonide Oral Suspension (BOS)
Number of subjects: 48
Study: 33723979

Group type: EXPERIMENTAL
Intervention: Test toothpaste containing 0.454% SnF2, 0.072% sodium fluoride, and 5% sodium tripolyphosphate (n = 67)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control toothpaste containing 0.76% sodium monofluorophosphate (n = 68)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Both Test and Control toothpastes
Number of subjects: 135
Study: 35064574

Group type: EXPERIMENTAL
Intervention: Caffeinated coffee enriched with cocoa and fructo-oligosaccharides (FOS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Decaffeinated coffee enriched with cocoa and fructo-oligosaccharides (FOS)
Number of subjects: 0
Study: 34363050

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure management (target systolic BP <120 mmHg)
Number of subjects: 7738

Group type: COMPARATOR
Intervention: Standard blood pressure management (target systolic BP ≥120 mmHg)
Number of subjects: 7738
Study: 33753445

Group type: EXPERIMENTAL
Intervention: Prophylactic low molecular weight heparin (LMWH)
Number of subjects: 0
Study: 33332403

Group type: EXPERIMENTAL
Intervention: Mindfulness intervention
Number of subjects: 3

Group type: COMPARATOR
Intervention: Active-control (music listening)
Number of subjects: 3
Study: 34240659

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation at 4,000 IU/day for 6 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 34752255

Group type: EXPERIMENTAL
Intervention: Electric 3D toothbrush (Oral-B Pro-1000 with Oral-B Ortho head)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Manual toothbrush (Oral-B Orthodontic brush)
Number of subjects: 80
Study: 32106757

Group type: EXPERIMENTAL
Intervention: Gutbusters+Incentive
Number of subjects: 102

Group type: COMPARATOR
Intervention: Gutbusters alone
Number of subjects: 102
Study: 35627496

Group type: EXPERIMENTAL
Intervention: Supervised group physical exercise
Number of subjects: 282

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: WHO-5 score ≤ 50
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: WHO-5 score > 50
Number of subjects: 282
Study: 32557560

Group type: EXPERIMENTAL
Intervention: Spatial regression model with Gaussian random effects for the intervention arm.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Orthogonal regression to avoid spatial confounding.
Number of subjects: 0
Study: 34913281

Group type: EXPERIMENTAL
Intervention: Antioxidant-rich dietary intervention (3 meal boxes daily for 4 weeks)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Antioxidant-rich dietary intervention
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (usual diet)
Number of subjects: 31
Study: 34602400

Group type: EXPERIMENTAL
Intervention: Celecoxib combined with glucosamine hydrochloride therapy
Number of subjects: 128

Group type: COMPARATOR
Intervention: Celecoxib tablet therapy
Number of subjects: 128
Study: 34446791

Group type: EXPERIMENTAL
Intervention: Neurofeedback training (NFB) with theta/low-beta power ratio on EEG for 3 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 0
Study: 33202559

Group type: EXPERIMENTAL
Intervention: MET + TPT
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: MET
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: TPT
Number of subjects: 60
Study: 36307989

Group type: EXPERIMENTAL
Intervention: Topical gentamicin cream delivered via platform wound device (PWD)
Number of subjects: 0
Study: 33694287

Group type: EXPERIMENTAL
Intervention: gshCBT
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: gshBWL
Number of subjects: 140

Group type: COMPARATOR
Intervention: CON
Number of subjects: 140
Study: 32246899

Group type: EXPERIMENTAL
Intervention: 100 mg of 4-fluoroamphetamine (4-FA)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 150 mg of 4-fluoroamphetamine (4-FA) in 150 mL Royal Club bitter lemon drink
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 33237839

Group type: EXPERIMENTAL
Intervention: 25-Hydroxyvitamin D (25(OH)D) plasma levels
Number of subjects: 35
Study: 33593885

Group type: EXPERIMENTAL
Intervention: Everolimus
Number of subjects: 108

Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 108
Study: 35603416

Group type: EXPERIMENTAL
Intervention: Mindfulness intervention (audio-guided mindfulness exercise)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control exercise
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Mindfulness intervention
Number of subjects: 61
Study: 34217593

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2524
Study: 32036479

Group type: EXPERIMENTAL
Intervention: Implementation support for evidence-based physical health care
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Policies stating physical health care standards
Number of subjects: 13
Study: 35768986

Group type: EXPERIMENTAL
Intervention: Oral ketamine
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 32585392

Group type: EXPERIMENTAL
Intervention: Turmeric and mefenamic acid (500 mg and 250 mg respectively)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Mefenamic acid (250 mg)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Turmeric (500 mg)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Turmeric and mefenamic acid combination
Number of subjects: 128
Study: 35148511

Group type: EXPERIMENTAL
Intervention: aprotinin
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: tranexamic acid (TXA)
Number of subjects: 90

Group type: COMPARATOR
Intervention: no intervention (control)
Number of subjects: 90
Study: 32538882

Group type: EXPERIMENTAL
Intervention: Walkbot locomotor training (WLT)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Conventional locomotor training (CLT)
Number of subjects: 14
Study: 35266571

Group type: COMPARATOR
Intervention: TIPS alone (TIPS group)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: TIPS plus simultaneous SPSS embolization (TIPS+E group)
Number of subjects: 56
Study: 36251574

Group type: EXPERIMENTAL
Intervention: Neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin (ddMVACx6)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Four cycles of gemcitabine and cisplatin (GCx4)
Number of subjects: 0
Study: 34000004

Group type: EXPERIMENTAL
Intervention: TriGuard™ HDH cerebral embolic deflection device (TG)
Number of subjects: 258

Group type: COMPARATOR
Intervention: Control (no TG)
Number of subjects: 258
Study: 34666014

Group type: EXPERIMENTAL
Intervention: Distal radial access (DRA)
Number of subjects: 1300

Group type: COMPARATOR
Intervention: Conventional transradial access (TRA)
Number of subjects: 1300
Study: 34535086

Group type: EXPERIMENTAL
Intervention: Desflurane (DES-group)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Sevoflurane (SEVO-group)
Number of subjects: 44
Study: 32340502

Group type: EXPERIMENTAL
Intervention: TEAS combined with diazepam
Number of subjects: 117

Group type: COMPARATOR
Intervention: Sham TEAS combined with diazepam
Number of subjects: 117
Study: 35820575

Group type: EXPERIMENTAL
Intervention: Trauma Center Trauma-Sensitive Yoga (TCTSY; n = 17)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Cognitive Processing Therapy (CPT; n = 24)
Number of subjects: 41
Study: 33978382

Group type: EXPERIMENTAL
Intervention: miR‐182 inhibitor
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: miR‐182 mimics
Number of subjects: 60

Group type: COMPARATOR
Intervention: miR‐182 expression levels
Number of subjects: 60

Group type: COMPARATOR
Intervention: miR‐182 in plasma samples
Number of subjects: 60
Study: 32762989

Group type: EXPERIMENTAL
Intervention: Composite Time Trade-Off (cTTO)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Discrete Choice Experiment (DCE)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: DCE (N = 300)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: DCE (N = 700)
Number of subjects: 1000
Study: 34276440

Group type: EXPERIMENTAL
Intervention: Lorcaserin
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 33826080

Group type: EXPERIMENTAL
Intervention: HLX02
Number of subjects: 649

Group type: COMPARATOR
Intervention: EU-trastuzumab
Number of subjects: 649
Study: 33038141

Group type: EXPERIMENTAL
Intervention: 10 μg vaginal estrogen therapy (ET) for 52 weeks
Number of subjects: 205
Study: 35998969

Group type: EXPERIMENTAL
Intervention: [68Ga]Ga-PentixaFor PET/CT
Number of subjects: 0

Group type: COMPARATOR
Intervention: AVS
Number of subjects: 0
Study: 32445952

Group type: COMPARATOR
Intervention: Improved Standard American Diet (iSAD)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Low-Fat, High-Fiber Diet (LFD)
Number of subjects: 17
Study: 32534646

Group type: EXPERIMENTAL
Intervention: Atezolizumab, vemurafenib, and cobimetinib
Number of subjects: 514

Group type: COMPARATOR
Intervention: Atezolizumab placebo, vemurafenib, and cobimetinib
Number of subjects: 514
Study: 36130744

Group type: EXPERIMENTAL
Intervention: Physiotherapy and stretching applied from the beginning of the appearance of the axillary cord, controlled and scheduled by the physiotherapist.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified what the control intervention is).
Number of subjects: 0
Study: 33428709

Group type: EXPERIMENTAL
Intervention: Intensive Lifestyle (ILS)
Number of subjects: 2385

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 2385

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2385
Study: 34528271

Group type: EXPERIMENTAL
Intervention: Decision Aids (DAs) - one-page Option GridTM, four-page paper tool, 17-minute video, interactive website
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Decision Aids (DAs)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 21
Study: 35930199

Group type: EXPERIMENTAL
Intervention: Multisectoral intervention (Shamba Maisha)
Number of subjects: 30
Study: 32496814

Group type: EXPERIMENTAL
Intervention: NYU Caregiver Intervention (NYUCI) provided by ten Israeli clinicians (enhanced care)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Support group participation (usual care)
Number of subjects: 100
Study: 32496566

Group type: EXPERIMENTAL
Intervention: Presession D-Cycloserine (DCS)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Postsession D-Cycloserine (DCS)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Tailored D-Cycloserine (DCS)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152
Study: 34663135

Group type: EXPERIMENTAL
Intervention: Culture-sensitive Pain Neuroscience Education (CSPNE)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Standard Pain Neuroscience Education (PNE)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 53
Study: 32804266

Group type: EXPERIMENTAL
Intervention: Video feedback
Number of subjects: 51

Group type: COMPARATOR
Intervention: Verbal feedback
Number of subjects: 51

Group type: COMPARATOR
Intervention: Self-assessment
Number of subjects: 51
Study: 36334128

Group type: COMPARATOR
Intervention: Sitting Only (SO)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Sitting Plus Standing (SSt)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Exercise Plus Sitting (ES)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Exercise Plus Sitting Plus Standing (ESSt)
Number of subjects: 15
Study: 32543021

Group type: EXPERIMENTAL
Intervention: Exenatide (10 μg) administered three times daily for 26 weeks
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo administered three times daily for 26 weeks
Number of subjects: 108
Study: 35045736

Group type: EXPERIMENTAL
Intervention: Mindful Walking (MFW)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Moderate Walking (MW)
Number of subjects: 51
Study: 34935709

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT, 3‐min intervals at 80% and 40% maximal O2, n = 20)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MICT, sustained 60% maximal O2, n = 20)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (n = 20)
Number of subjects: 60
Study: 32369766

Group type: EXPERIMENTAL
Intervention: Strength training with peer support
Number of subjects: 51

Group type: COMPARATOR
Intervention: Strength training alone
Number of subjects: 51
Study: 36169043

Group type: EXPERIMENTAL
Intervention: Toric contact lenses
Number of subjects: 23

Group type: COMPARATOR
Intervention: Spherical equivalent contact lenses
Number of subjects: 23
Study: 33402377

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy Skills Scale
Number of subjects: 847
Study: 34779220

Group type: EXPERIMENTAL
Intervention: Early surgical aortic valve replacement (SAVR)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 157
Study: 33472462

Group type: EXPERIMENTAL
Intervention: Non-contact infrared thermometers (NCIT)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Infrared tympanic thermometers (ITT)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Mercury axillary thermometers (MAT)
Number of subjects: 45
Study: 32433277

Group type: EXPERIMENTAL
Intervention: Enhanced recovery pathway (17 evidence-based pre-, intra-, and postoperative care elements)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Enhanced recovery pathway
Number of subjects: 56

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 56
Study: 33740353

Group type: EXPERIMENTAL
Intervention: Hemoglobin A1c (HbA1c) levels in patients with FM
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: QUICKI and HOMA‐IR indices in a subgroup of FM patients
Number of subjects: 33
Study: 35820992

Group type: EXPERIMENTAL
Intervention: School-based mindfulness training (SBMT)
Number of subjects: 8376

Group type: COMPARATOR
Intervention: Teaching-as-usual (TAU)
Number of subjects: 8376
Study: 34508694

Group type: EXPERIMENTAL
Intervention: Cryoballoon ablation (CBA)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Antiarrhythmic drugs (AAD)
Number of subjects: 218
Study: 36000934

Group type: EXPERIMENTAL
Intervention: Rifapentine/isoniazid (3HP)
Number of subjects: 896

Group type: EXPERIMENTAL
Intervention: Rifampin/isoniazid (3HR)
Number of subjects: 896

Group type: COMPARATOR
Intervention: Isoniazid for 6 months
Number of subjects: 896

Group type: COMPARATOR
Intervention: Isoniazid continuously
Number of subjects: 896

Group type: EXPERIMENTAL
Intervention: Preventive treatment (8 rifamycin and 26 isoniazid monotherapy)
Number of subjects: 896
Study: 33842907

Group type: EXPERIMENTAL
Intervention: Selenite 200 μg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Selenite 50 μg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 36429439

Group type: EXPERIMENTAL
Intervention: High-Intensity Group (HG) - 80% of maximal inspiratory pressure (MIP) for 6 weeks, 6 breaths a set, 4 sets a day, totaling 24 breaths a day.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Low-Intensity Group (LG) - 30% of maximal inspiratory pressure (MIP) for 6 weeks, 6 breaths a set, 4 sets a day, totaling 24 breaths a day.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control Group (CG) - no intervention.
Number of subjects: 30
Study: 33086370

Group type: EXPERIMENTAL
Intervention: Evaluation mode (participant observes and evaluates the team player)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Game play mode (participant is immersed as the leader)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both modes (evaluation and game play)
Number of subjects: 120
Study: 32266197

Group type: EXPERIMENTAL
Intervention: Mechanical massage and mental training combined
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Mechanical massage
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Mental training
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Pause
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control
Number of subjects: 93
Study: 33357491

Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 319349

Group type: COMPARATOR
Intervention: No diabetes
Number of subjects: 319349

Group type: EXPERIMENTAL
Intervention: Diabetes (adjusted for age and sex)
Number of subjects: 319349

Group type: EXPERIMENTAL
Intervention: Type 1 diabetes
Number of subjects: 319349

Group type: EXPERIMENTAL
Intervention: Type 2 diabetes
Number of subjects: 319349

Group type: EXPERIMENTAL
Intervention: Diabetes risk factors
Number of subjects: 319349

Group type: EXPERIMENTAL
Intervention: Predictive model for COVID-19 in diabetes
Number of subjects: 319349
Study: 32962031

Group type: EXPERIMENTAL
Intervention: Co-active coaching intervention for three months
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Health education intervention for three months
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Co-active coaching intervention
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Health education intervention
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 50
Study: 35868015

Group type: EXPERIMENTAL
Intervention: High-carbohydrate diet (CHO; 1 g CHO·kg ‐1 ·h ‐1)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Low-carbohydrate placebo diet (PLA; <0.1 g CHO·kg ‐1 ·h ‐1)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Low-carbohydrate placebo diet (PLA)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: High-carbohydrate diet (CHO)
Number of subjects: 18
Study: 34476479

Group type: EXPERIMENTAL
Intervention: Music-based executive function intervention
Number of subjects: 29

Group type: COMPARATOR
Intervention: Art class control activity
Number of subjects: 29
Study: 33899655

Group type: EXPERIMENTAL
Intervention: risankizumab
Number of subjects: 2046
Study: 33153764

Group type: EXPERIMENTAL
Intervention: PDSAFE intervention (multi-dimensional, individually tailored and progressive, home-based programme)
Number of subjects: 2587
Study: 35187813

Group type: EXPERIMENTAL
Intervention: CAD/CAM
Number of subjects: 20

Group type: COMPARATOR
Intervention: Lost-wax
Number of subjects: 20
Study: 33840367

Group type: EXPERIMENTAL
Intervention: Full windshield head-up display (FHUD)
Number of subjects: 48

Group type: COMPARATOR
Intervention: No full windshield head-up display (Control)
Number of subjects: 48
Study: 36041770

Group type: EXPERIMENTAL
Intervention: Sufentanil TCI
Number of subjects: 270

Group type: COMPARATOR
Intervention: Remifentanil TCI
Number of subjects: 270
Study: 32799726

Group type: EXPERIMENTAL
Intervention: Amoxicillin and azithromycin
Number of subjects: 78

Group type: COMPARATOR
Intervention: Erythromycin
Number of subjects: 78
Study: 34069350

Group type: EXPERIMENTAL
Intervention: Effective coping mechanisms instead of smoking to deal with stress
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Strengthening effective coping skills
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Increasing perceived control and self-efficacy
Number of subjects: 39
Study: 34360187

Group type: EXPERIMENTAL
Intervention: MooN program (SEM intervention)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Traditional model of direct instruction (TM-DI)
Number of subjects: 170
Study: 34538089

Group type: EXPERIMENTAL
Intervention: MRI assessment of brain infarcts
Number of subjects: 918

Group type: COMPARATOR
Intervention: Prior stroke/transient ischemic attack
Number of subjects: 918

Group type: COMPARATOR
Intervention: Modified Rankin Scale score >0
Number of subjects: 918

Group type: COMPARATOR
Intervention: Current tobacco use
Number of subjects: 918
Study: 33508848

Group type: COMPARATOR
Intervention: Aromatherapy
Number of subjects: 93

Group type: COMPARATOR
Intervention: Massage therapy
Number of subjects: 93

Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 93
Study: 34470478

Group type: EXPERIMENTAL
Intervention: Saturated fat (1000 kcal/day for 3 weeks)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Unsaturated fat (1000 kcal/day for 3 weeks)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Simple sugars (CARB) (1000 kcal/day for 3 weeks)
Number of subjects: 36
Study: 32340519

Group type: EXPERIMENTAL
Intervention: Functional endoscopic sinus surgery (FESS)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Open frontal sinus surgery
Number of subjects: 64